Apr 28, 2020   SOURCE: PR NewsWire

Brenntag Canada and Fuji Chemical Industries Announce Exclusive Distribution Agreement

READING, Pa., April 28, 2020 /PRNewswire-PRWeb/ -- Fuji's premium line of excipients is produced using their spray drying capabilities and includes Neusilin®, Fujicalin®, F-MELT®, and FujiSil(TM). 

    --  Neusilin® - is Magnesium Aluminometasilicate USP/EP/JP. It improves
        powder flowability, is an excellent adsorbent for oily actives, is an
        anticaking agent, and acts as a stabilizer for deliquescent drugs.
    --  Fujicalin® - is a unique form of Dibasic Calcium Phosphate Anhydrous
        (DCPA). It provides flowability, rapid disintegration, high direct
        compressibility, high oil adsorption capability, is non-abrasive, and
        can improve survivability of probiotics during tableting.
    --  F-MELT® - ready-to-use excipient base for ODTs. It provides an easy way
        to produce fast melt tablets on conventional tableting equipment that
        disintegrate within 30 seconds. It is directly compressible, extremely
        flowable, and produces tablets with excellent mouth feel.
    --  FujiSil(TM) - is a unique form of Silicon Dioxide USP/NF. It is a
        versatile excipient that has superior adsorption properties and can turn
        oily actives into a free-flowing powder, improve tabletability, be used
        as a carrier for solid dispersions, and aids in moisture protection.

"The addition of Fuji's premium line of excipients is a testament to our dedication in strengthening our overall offering to the Canadian Pharmaceutical and Nutraceutical markets," states Jim Sally, Vice President, Brenntag Canada. "The addition of this product line to our current portfolio and dedicated technical staff gives Brenntag a solid and exciting value proposition for our customers."

Since 1946, Fuji has been producing excipients at their manufacturing site in Toyama, Japan. These excipients can be used in pharmaceutical, dietary supplement, nutraceutical, personal care, and CBD/cannabis applications.

"We are pleased to add Fuji Chemical's specialty excipients to the Pharmaceutical and ingredients portfolio at Brenntag. This exclusive agreement will benefit our customer base by providing a local touch to support their development," said Anne-Marie Gaudet, Pharmaceutical Industry Manager, Brenntag Canada.

About Brenntag:

Brenntag is the global market leader in chemical and ingredients distribution. We connect our suppliers and customers in value-adding partnerships. Our almost 17,500 employees provide tailor-made application, marketing and supply chain solutions. Technical and formulation support, market, industry and regulatory expertise as well as advanced digital tools are just some examples of our services that are aiming to create an excellent customer experience. Our full-line portfolio comprises specialty and industrial chemicals and ingredients of a world-class supplier base. Building on its long-standing experience, unmatched global reach and local excellence, Brenntag works closely alongside its partners to make their business more successful. We are committed to contribute towards greater sustainability in our own business and the industries we serve, and to achieve sustainable profitable growth. Headquartered in Essen (Germany) and with regional headquarters in Philadelphia, Houston and Singapore, Brenntag operates a unique global network with more than 640 locations in 77 countries. The company generated sales of EUR 12.8 billion (USD 14.4 billion) in 2019. Brenntag shares are traded at the Frankfurt Stock Exchange (BNR).

For more information on Brenntag North America, please visit http://www.brenntagnorthamerica.com.

About Fuji Chemical Industries co., LTD, USA, Inc .:

Fuji Chemical Industries Co., Ltd. is engaged in the production and sale of pharmaceutical products/synthesis, the manufacture of pharmaceutical and bulk pharmaceutical products, and the production and sale of food additives. It offers contract manufacturing services that include API manufacturing; functional APIs, such as drug intermediates; and drug products manufacturing. The company also provides excipients and drug delivery systems.

For more information on Fuji Chemical Industries USA, Inc, please visit http://www.fujichemicalusa.com.

Credits: The Brenntag and ConnectingChemistry logos are registered trademarks of Brenntag AG or its subsidiaries. Neusilin®, Fujicalin®, F-MELT® and FujiSil(TM) are registered trademarks of Fuji Chemical Industries USA, Inc. Any other trademarks are the property of their respective owners.

SOURCE Brenntag North America